NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

CeriBell, Inc. (CBLL) Stock Analysis

CeriBell, Inc. (CBLL) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

CBLL

$27.14

−$0.54 (−1.95%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare CBLL with… →

CBLL Key Statistics

As of Oct 21, 2026
Trading
Open
$27.64
Previous Close
$27.68
Day's Range
27.01–28.11
52-Week Range
10.85–26.72
Volume
472.01K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.93
Valuation
Market Cap
$1.01B
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
9.93
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.76
Financials (FY)
Revenue (FY)
$89.06M+36.09%
Net Income (FY)
−$53.41M
Profit marginThe share of revenue left as profit after all costs and taxes.
−64.73%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
38.38M
1-Year Return
+102.84%
Dividend and dates
Earnings Date
November 3, 2026estimated
Avg Volume
381.41K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, CBLL closed at $27.14, +102.84% over 1 year.

CeriBell, Inc. (CBLL) has a market capitalization of $1.01B.

In fiscal 2025, CBLL reported revenue of $89.06M.

CBLL Stock Return by Calendar Year

CeriBell, Inc. (CBLL) return since Oct 2024: what $10,000 became

1 year
$10,000 $20,284
+102.84%
Since Oct 2024
$10,000 $10,856
+8.56%

If you had invested $10,000 in CeriBell, Inc. (CBLL) at the close on October 11, 2024, the earliest close on record here, it would have been worth $10,856 at the close on October 21, 2026: +8.56% in total, +4.14% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+23.76%
2025−15.26%
2024 (partial year)+3.52%

As of October 21, 2026.

CBLL Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$89.06M−$53.41M−60.0%
2024$65.44M−$40.46M−61.8%
2023$45.23M−$29.46M−65.1%
2022$25.92M−$37.16M−143.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$89.06M$78.27M−$58.40M−$53.41M−60.0%
2024$65.44M$56.75M−$39.71M−$40.46M−61.8%
2023$45.23M$38.16M−$30.04M−$29.46M−65.1%
2022$25.92M$21.49M−$36.02M−$37.16M−143.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

CBLL Valuation vs Medical Devices Median

Median of 145 stocks
MetricCBLLMedical Devices medianvs median
P/S ratio9.932.533.9x the median
Profit margin−64.73%−14.78%49.9 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 15 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values CeriBell, Inc. (CBLL) at $1.01B. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 327.

CBLL last closed at $27.14 on October 21, 2026. That is −$0.54 (−1.95%) against the previous close. Over the past 52 weeks the price has ranged from $10.85 to $26.72. The latest close sits 150.14% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $89.06M. Against the prior fiscal year total of $65.44M, that is a change of +36.09%. The same year closed with a net loss of $53.41M. Profit margin runs at −64.73%. That is 49.9 percentage points below the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to −1.76.

Across the 4 fiscal years on file, revenue moves from $25.92M in 2022 to $89.06M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 9.93 times revenue. On price-to-sales that is 3.9 times the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

The reported beta is 0.93. Daily returns over the trailing 2 years annualize to a volatility of 66.09%. Over the trailing twelve months the total return is +102.84%. The stored price history starts on October 11, 2024, and the total return since then is +8.56%.

Growth & Income

The record shows no dividend for CBLL.

The record holds one complete calendar year, 2025, which returned −15.26%. 2026 is still running; the total return is +23.76% year to date.

Peer Comparison

CeriBell, Inc. (CBLL) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
CeriBell, Inc. CBLL $1.01B —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. CeriBell, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About CeriBell, Inc.

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Visit website →